Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Total Liabilities (2020 - 2025)

Historic Total Liabilities for KORU Medical Systems (KRMD) over the last 10 years, with Q3 2025 value amounting to $10.6 million.

  • KORU Medical Systems' Total Liabilities rose 1017.08% to $10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 million, marking a year-over-year increase of 1017.08%. This contributed to the annual value of $10.4 million for FY2024, which is 2834.07% up from last year.
  • According to the latest figures from Q3 2025, KORU Medical Systems' Total Liabilities is $10.6 million, which was up 1017.08% from $9.0 million recorded in Q2 2025.
  • In the past 5 years, KORU Medical Systems' Total Liabilities ranged from a high of $11.0 million in Q4 2022 and a low of $3.3 million during Q2 2021
  • Over the past 5 years, KORU Medical Systems' median Total Liabilities value was $8.6 million (recorded in 2024), while the average stood at $8.3 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first surged by 19503.83% in 2022, then tumbled by 2634.16% in 2023.
  • KORU Medical Systems' Total Liabilities (Quarter) stood at $4.8 million in 2021, then surged by 129.69% to $11.0 million in 2022, then fell by 26.34% to $8.1 million in 2023, then rose by 28.34% to $10.4 million in 2024, then grew by 2.25% to $10.6 million in 2025.
  • Its last three reported values are $10.6 million in Q3 2025, $9.0 million for Q2 2025, and $10.9 million during Q1 2025.